NexaOnco Therapeutics Case Study
The following case study demonstrates an omnichannel approach to medical communications for a fictional pharmaceutical company's drug discovery pipeline. To provide realistic depth and context, asset text has been generated using AI.
The case study includes three assets: The Drug Discovery Pipeline Congress Interactive, the ESMO Congress Emailer, and the HORIZON-MM Clinical Trial Banner Ads.
Drug Discovery Pipeline Congress Interactive
Designed for standard 1920x1080 px congress displays, this interactive pipeline tool offers two engagement approaches: Medical Science Liaisons (MSLs) can guide Healthcare Professionals (HCPs) through a curated tour of the NexaOnco pipeline, or users can explore the content independently.
ESMO Congress Emailer
Designed as a pre-congress engagement tool, MSLs can send this emailer to HCPs ahead of the European Society For Medical Oncology (ESMO) Congress to raise awareness of NexaOnco’s submitted abstracts. By leveraging Veeva email tokens and deploying through the Veeva platform, the template allows for customization.
HORIZON-MM Clinical Trial Banner Ads
Designed for versatile deployment, these banner ads are optimized for use across clinical websites, medical newsletters, and healthcare mobile apps. Keeping the target audience in mind, the banners leverage HCP-facing language rather than plain language patient terminology.
